发明名称 CYCLOOXYGENASE-2 INHIBITOR COMPOSITIONS HAVING RAPID ONSET OF THERAPEUTIC EFFECT
摘要 Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising a selective cyclooxygenase-2 inhibitory drug of low water solubility in a therapeutically effective amount, wherein the drug is present in the form of solid particles, about 25 % to 100 % by weight of which are smaller than 1 mu m. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders and have particular advantages where rapid onset of therapeutic effect is desired.
申请公布号 WO0141760(A2) 申请公布日期 2001.06.14
申请号 WO2000US32434 申请日期 2000.12.06
申请人 PHARMACIA CORPORATION;KARARLI, TUGRUL, T.;KONTNY, MARK, J.;DESAI, SUBHASH;HAGEMAN, MICHAEL, J.;HASKELL, ROYAL, J. 发明人 KARARLI, TUGRUL, T.;KONTNY, MARK, J.;DESAI, SUBHASH;HAGEMAN, MICHAEL, J.;HASKELL, ROYAL, J.
分类号 C07D233/60;A61K9/14;A61K9/20;A61K9/24;A61K9/26;A61K9/48;A61K9/50;A61K31/34;A61K31/341;A61K31/352;A61K31/41;A61K31/415;A61K31/42;A61K31/44;A61K31/444;A61K45/00;A61K45/06;A61P1/00;A61P1/02;A61P1/04;A61P1/16;A61P3/10;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P15/00;A61P15/04;A61P17/00;A61P17/02;A61P17/06;A61P17/10;A61P19/02;A61P19/10;A61P21/00;A61P21/04;A61P25/00;A61P25/06;A61P25/28;A61P25/32;A61P27/02;A61P27/12;A61P29/00;A61P31/12;A61P31/18;A61P35/00;A61P37/08;A61P43/00;C07D213/61;C07D231/12;C07D261/08;C07D307/58;C07D311/58;(IPC1-7):A61K31/415;A61K9/51 主分类号 C07D233/60
代理机构 代理人
主权项
地址